My image My image My image
May 30, 2018
ViroMed Announces Publication of VM202’s MoA in Nerve Regeneration
May 23, 2018
VM BioPharma Presents at Pain Therapeutics Conference in UK
May 18, 2018
Reyon’s Lawsuit Dismissed by Court
May 15, 2018
Five Korean Companies’ Stocks Join MSCI Index
May 10, 2018
Global Market Report Forecasts ViroMed’s VM202 Will Become First Disease-Modif...
Apr 17, 2018
ViroMed Announces Publication of VM202’s MoA in Reducing Neuropathic Pain